"False hope" is a bold take for a drug with a 90% real world continuation rate and a confirmatory study fully enrolled since 2023. C'mon. Let the data answer the clinical benefit question before the headlines write the verdict #RareDisease #DMD #AcceleratedApproval #LetTheScienceLead